That is essential, since the method a protein in the human body folds determines if a pharmaceutical will be able to bind to that protein and be reliable. Simply put, we have to understand how these proteins fold if we want a drug to work. Historically, this has actually been a trial-and-error procedure (last week). Now, Alpha, Fold can anticipate protein folding with 92. 4% precision. That's going to make it a lot easier to develop drugs that do what they're designed to do. This was a breakthrough practically nobody discovered. However it's going to have profound ramifications for curing disease. I forecast that Alpha, Fold will be 98% accurate by the end of 2021.
And, obviously, there will be lots of investment opportunities in this area, too. Moving topics It's going to be a good year for bitcoin. I'm bullish on it in 2021 (melania trump). That stated, I still believe bitcoin will continue to be volatile. We're close to all-time highs. I wouldn't be shocked if it pulled back maybe substantially prior to going higher - exponential growth. I've been covering bitcoin for a long period of time now. One of the first research reports I ever published was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that initial recommendation, I titled my report "What's the Big Offer With Bitcoin?" That reveals you where the discussion was at the time. We were mostly educating readers. But that's not the huge question anymore. Now we're seeing institutional money finally take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, specific niche business. Mass, Mutual is a trusted 170-year-old institution. So think of that. In 5 years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
Which's a big factor I'm bullish on it this year. last year. Regards, Jeff Brown, Editor, The Bleeding Edge I have a reward forecast 2020 was a record year for IPOs. 552 U.S. business went public the most in more than twenty years. These business raised a total of $172 billion. That's an all-time high beating the previous annual record by 43%. I anticipate 2021 will be another record year in IPOs. There are a lot of excellent private companies on the brink of hitting the public markets And I have actually been dealing with a brand-new method for you to invest even before these companies go public.
This opportunity has actually been constructing over the last couple of years. I can't wait to inform you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to learn all the information. Go right here to book your spot for free.
Emma Walsh here, handling editor of the Diary. Regular Diary readers understand that tech isn't our usual beat (biotech stocks jeff brown). And when it concerns tech investing, we leave it to the professionals. Luckily, we have a number of such specialists in our Rolodex. Our associate Jeff Brown will recognize to our long time readers. He is among the most accomplished tech investing professionals we know (jeff brown stock market prediction). In reality, he had numerous triple-digit returns in his Brownstone Research portfolios last year. Here's what Jeff thinks the tech sector will bring us in 2021 Each year, I like to have a look at the huge picture and forecast what's just around the corner.
That includes things like 5G networks, biotech, synthetic intelligence, and much more. These patterns are experiencing rapid growth and developing incredible chances for financiers. I wish to ensure all our readers are prepared for what's next. And with that in mind, let me draw the photo of what I see being available in the next 12 months Our new 5G (fifth-generation) wireless networks are a topic I've been covering for years now. jeff brown biotech stocks. But regardless of what many readers might think, this is a trend that's just beginning. Even though the COVID-19 pandemic interfered with supply chains in 2015, an excellent 250 million 5G-enabled devices were still offered.
And all of this ultimately caused Apple delaying the release of the 5G-enabled i, Phone 12 by 2 months (biotech stock). Losing 2 months of manufacturing and sales truly affects how many 5G devices are sold in the fiscal year. When you think about all of that, offering 250 million systems is remarkable. More notably, the delays brought on by the pandemic produced a lot of bottled-up need. Which demand is now going to be pressed into 2021. In reality, I forecast that more than 500 million 5G gadgets will be delivered in 2021 - exponential tech investor. And that's not my only 5G prediction When I've talked about 5G in the past, I've explained its three different stages.
In Phase Two, 5G devices go on sale. 5G phones and other items start to reach consumers. And in Stage Three, 5G services start to be provided (jeff brown investor prediction). That's when we begin to see applications working on 5G networks. Consider things like enormous multiplayer games over a cellphone. That's not possible with 4G. It will be with 5G. And my second 5G forecast for 2021 is that we will start Stage Three by this summertime. This starts something of a virtuous cycle: Many people don't truly appreciate the technology. But they will care if there are amazing applications that can just be accessed with a 5G phone.
That leads to more 5G apps being established. In fact, 5G is going to open up a suite of amazing applications: self-driving vehicles, the Internet of Things, robotic surgical treatment, and more. All of these technologies require 5G. The financial investment opportunities moving forward will be huge. Stepping far from 5G, the next crucial innovation I anticipate in 2021 is CRISPR genetic modifying. CRISPR means "clustered frequently interspaced brief palindromic repeat." It's a mouthful. But it is among the most amazing developments in biotechnology. At a high level, CRISPR is a technology that can modify our genetic makeup as if it were software application.
The program can crash or not function correctly. CRISPR utilizes a similar idea but with our genetic code. "Typos" in our genome can cause disease. CRISPR can fix these "typos." For years, CRISPR was mainly a niche innovation that wasn't well comprehended. And throughout that time, there were actually only 3 companies running in this space. However things are altering. CRISPR is no longer simply theoretical. We're seeing real results. We're dealing with illness and seeing that this innovation just works. And as a result, a "second crop" of early-stage CRISPR companies is going public and providing incredible returns. This whole market is successfully a greenfield opportunity.
There's space for lots of business to exist in this area. self-driving cars. And there will be more. That's my prediction for CRISPR in 2021. I forecast that two or 3 more genetic editing companies will hold their IPOs. Sticking to biotechnology, we are seeing incredible things taking place at the convergence of biotech and expert system (AI). Google's AI subsidiary, Deep, Mind, simply announced at the end of 2020 that its latest Alpha, Fold software can accurately anticipate the folding of a protein based solely on its amino acid sequence with 92. 4% accuracy. That is necessary because the way a protein in the human body folds determines if a pharmaceutical will have the ability to bind to that protein and work.
Historically, this has actually been a trial-and-error process. However now, Alpha, Fold can predict protein folding with 92. 4% precision. That's going to make it a lot easier to produce drugs that do what they're designed to do. And here's my next forecast. I predict that Alpha, Fold will be 98% precise by the end of 2021. And we will see not just one but numerous drug therapies produced using this innovation. This was among those advancements that almost no one discovered. However it's going to have extensive implications for curing disease. And, naturally, there will be a lot of investment opportunities in this space, too.
It's going to be a great year for bitcoin. I'm bullish on it in 2021. That stated, I still think bitcoin will continue to be unpredictable. We're close to all-time highs. I would not be surprised if it pulled back maybe considerably prior to going higher. I have actually been covering bitcoin for a long period of time now. One of the first research study reports I ever published was on bitcoin - jeff brown genome sequencing. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on financial investment for anybody who followed my suggestion. However at the time of that preliminary recommendation, I titled my report, "What's the Big Offer With Bitcoin?" That reveals you where the discussion was at the time.
However no one is asking that concern anymore. Now, we're seeing institutional money finally taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, specific niche enterprise. self-driving cars. Mass, Mutual is a 150-year-old organization. So consider that. In five years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a huge reason that I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another bonus offer forecast In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown is worth about $27. 5 million and claims the information is up to date since February 2021, however we could not independently verify this claim. Provided Jeff Brown's past, he likely has a substantial net worth, however we can't hammer down an exact figure at this minute. Brown is best known for his sage-like ability to select winning innovation stocks. He invested more than 25 years investigating innovation companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's comprehensive experience offers him an excellent perspective on the market. He's always on the hunt for new chances, and he shares a number of his finest choices in the Future Report.
That's full marks, but it's not absurdly reasoned. Brown has an exceptional credibility as a stock-picker, and he effectively forecasted some of the greatest financial events of the previous 20 years. Although he does not appear to launch his choices to the general public, the service's success is a direct indicator of Brown's stock-picking expertise. No one on Wall Street gets it ideal every time, but Jeff Brown's precise forecasts have made him legions of dedicated fans. That says a lot about his ability. The Near Future Report is released by Brownstone Research, a prominent financial research publisher. Brownstone Research study uses numerous research study services with a variety of expertises - self-driving cars.
The business is likewise associated with Bonner & Partners, another well-respected research publisher - jeff brown. On its website, Brownstone states its objective is to provide retail investors with professional-grade research: "For too long, the finest financial investment research study has actually not been offered to individual financiers. It has been usually booked for investment banks, hedge funds, private equity, and high-net-worth customers. tech stocks. The objective of Brownstone Research study is to make that type of proprietary research readily available to any investors seeking to acquire an edge in the markets. The objective is basic to provide distinct and profitable investment research study discovered nowhere else." -Brownstone Research site excerpt from the Jeff Brown is the founder of Brownstone Research study, and he also works as the firm's Chief Investment Analyst.
With Brown guiding the ship, Brownstone Research study is a powerhouse publisher with lots to use its customers. After years of constant success at the helm of top-tier business like Tesla and Space, X, Elon Musk is a home name throughout the majority of America. If you know even a little bit about the market, you know that he has a credibility as a King Midas of sorts. jeff brown. Everything he touches turns to gold! Jeff is aware of Elon Musk's executive expertise, so he always has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next huge project.
In fact, Brown thinks S.A.V. jeff brown tech stock 2021. could be "the greatest pattern of the 2020s, and he's not alone. Take a look at these quotes from other popular S.A.V. bulls: Elon's next big act will be marrying two advanced technologies: expert system and electrical vehicles. Musk hopes the mix will assist him develop the first fully-autonomous, self-driving cars and trucks ever. It's nothing short of the vehicle industry's Holy Grail. As you know, electric vehicles and self-driving car stocks have actually been huge this year, however the Wall Street device has actually approved buzz without much tangible outcome. In spite of a drastic boost in competition over the past few years, Brown still thinks Musk has the very best opportunity of putting all of it together.
tech could be the magic string that connects all of it together. S.A.V. stands for Shared Autonomous Automobile, and it could be the future of transport. Essentially, this technology would allow you to rent out your automobile as a self-governing, self-driving taxi when you're not using it. You simply get out of the automobile and press a button on an app that tells the cars and truck to "join the fleet." Next thing you know, you're relaxing on your couch while your cars and truck shuttles ride-sharers around town. Most importantly, you get to keep a significant piece of the revenues. It sounds outrageous, however it could be closed than you believe.